HSP90 inhibitor 17-AAG suppresses the proliferation of FLT3-ITD/D835 mutant AML cells

被引:0
|
作者
Katayama, Kazuhiro [1 ]
Noguchi, Kohji [1 ]
Sugimoto, Yoshikazu [1 ]
机构
[1] Keio Univ, Fac Pharm, Div Chemother, Tokyo, Japan
来源
CANCER SCIENCE | 2018年 / 109卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
J-1015
引用
收藏
页码:294 / 294
页数:1
相关论文
共 50 条
  • [41] The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells
    Saporita, Anthony J.
    Ai, Junkui
    Wang, Zhou
    PROSTATE, 2007, 67 (05): : 509 - 520
  • [42] NAD(P)H: Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG
    Kasai, Shuya
    Arakawa, Nobuyuki
    Okubo, Ayaka
    Shigeeda, Wataru
    Yasuhira, Shinji
    Masuda, Tomoyuki
    Akasaka, Toshihide
    Shibazaki, Masahiko
    Maesawa, Chihaya
    PLOS ONE, 2016, 11 (04):
  • [43] The Hsp90 inhibitor 17-AAG represses calcium-induced cytokeratin 1 and 10 expression in HaCaT keratinocytes
    Miyoshi, Sadanori
    Yamazaki, Shota
    Uchiumi, Asato
    Katagata, Yohtaro
    FEBS OPEN BIO, 2012, 2 : 47 - 50
  • [44] Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway
    Akira Wagatsuma
    Yuzo Takayama
    Takayuki Hoshino
    Masataka Shiozuka
    Shigeru Yamada
    Ryoichi Matsuda
    Kunihiko Mabuchi
    Molecular and Cellular Biochemistry, 2018, 445 : 45 - 58
  • [45] Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance
    O'Malley, Katherine J.
    Langmann, Gabrielle
    Ai, Junkui
    Ramos-Garcia, Raquel
    Vessella, Robert L.
    Wang, Zhou
    PROSTATE, 2012, 72 (10): : 1117 - 1123
  • [46] A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells
    Hanna, Reine
    Abdallah, Jad
    Abou-Antoun, Tamara
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [47] BCL2A1: A Novel Target in Refractory Acute Myeloid Leukemia with FLT3-ITD/D835 Dual Mutations
    Yamatani, Kotoko
    Ai, Tomohiko
    Saito, Kaori
    Yang, Haeun
    Ruvolo, Vivian
    Mak, Po Yee
    Kinjo, Sonoko
    Ikeo, Kazuho
    Harada, Hironori
    Katayama, Kazuhiro
    Miida, Takashi
    Konopleva, Marina
    Zhang, Weiguo
    Carter, Bing Z.
    Hayashizaki, Yoshihide
    Andreeff, Michael
    Tabe, Yoko
    BLOOD, 2020, 136
  • [48] Synthesis and biological evaluation of IPI-504, an aqueous soluble analog of 17-AAG and potent inhibitor of Hsp90
    Porter, James R.
    Ge, Jie
    Normant, Emmanuel
    Ali, Janid
    Dembski, Marlene S.
    Gao, Yun
    Georges, Asimina T.
    Grenier, Louis
    Patterson, Jon
    Sydor, Jens R.
    Wright, Jim
    Adams, Julian
    Tong, Jeffrey K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [49] Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway
    Wagatsuma, Akira
    Takayama, Yuzo
    Hoshino, Takayuki
    Shiozuka, Masataka
    Yamada, Shigeru
    Matsuda, Ryoichi
    Mabuchi, Kunihiko
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 445 (1-2) : 45 - 58
  • [50] Hsp90 inhibitor 17-AAG inhibits stem cell-like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway
    Shu, Xiong
    Liu, Huiqi
    Zhen, Rui
    Jie, Yongsheng
    Chen, Lei
    Qi, Hui
    Wang, Chao
    Wang, Renxian
    Chen, Dafu
    Ran, Yuliang
    ONCOLOGY REPORTS, 2020, 44 (01) : 313 - 324